GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ribokinase in C2 spacegroup

Analyse Crystal structure of human ribokinase in C2 spacegroup in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5BYC
Type
protein
Length
634 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribokinase
EC
2.7.1.15
UniProt
Q9H477
Ligands
NA
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibokinase (EC 2.7.1.15)protein31837% helix, 23% strandQ9H477
BRibokinase (EC 2.7.1.15)protein31638% helix, 23% strandQ9H477

Ligands and binding sites

  • NA · Sodium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16860.690.7798empty
25240.650.7665empty
3500.300.7612empty
4560.290.7516empty

Interfaces

1 interface between chains.

  • A–B · 1249 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • Q9H477 · AlphaFold monomer V2.0 prediction for ribokinase (Q9H477) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.